health mRNA and mTOR Inhibition Combo Shows Promise in Reprogramming Allergic Immune Responses
Preclinical research reveals that combining mRNA-LNP therapy with mTOR inhibition promotes immune tolerance, reduces allergic asthma markers, and enhances safety profiles.
